Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study.
about
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitisOral 5-aminosalicylic acid for induction of remission in ulcerative colitisRectal 5-aminosalicylic acid for induction of remission in ulcerative colitisRetarded release phosphatidylcholine benefits patients with chronic active ulcerative colitisMucosal healing and deep remission: what does it mean?Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.Review article: treatment of mild to moderate ulcerative colitis and pouchitis.Review article: diagnosis, monitoring and treatment of distal colitis.Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.State of the art: IBD therapy and clinical trials in IBD.Systematic review: the use of mesalazine in inflammatory bowel disease.Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.The risks and the benefits of mesalazine as a treatment for ulcerative colitis.Quality of care for patients with inflammatory bowel disease in East China.Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: results of a meta-analysis of clinical trials."Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion.Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis.Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease.Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis.Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.
P2860
Q24185876-016967CF-3E48-49BC-8515-933C57E0450CQ24198024-B24691A8-B857-4A31-BE2D-53150B9CFF5BQ24240567-408F0AF4-D86E-439A-9FDD-AF767368F7A6Q24685584-6EC8FA35-B94F-4FAC-A67C-13B74ACDC473Q26852447-221B4056-4625-4B5A-BD39-3A9394FEF348Q34425918-D05132F9-AD02-452B-A9CA-6F1B63F01814Q34669202-909A6779-61DC-46B1-BEA0-35D83F026E01Q35144997-696AF4C9-2C8A-4FC6-9B44-BB71853EA107Q35629109-EC606FD4-BA90-493D-AB8E-040812B39B51Q36299319-37251D7B-6DEA-4B1C-A23D-3407B671E13EQ36435889-E849E433-74AE-43DA-A92F-23227B4241FEQ36578893-257F1A45-8C93-4395-9FCF-82C3CCE9133BQ36762423-3ABF332F-B808-49C1-9F72-B3D1A6232A44Q37059857-B0CA458E-DDB3-485D-878D-E46C2C01E8AFQ37959710-1CEA2EA1-F162-40FA-8E7A-DE418302B60FQ37993821-680183A2-688C-4B5A-A752-05415ABD7495Q38217234-F3D595D1-2D68-4D75-8121-260AC08FBC1AQ38505808-3A898A88-A72A-4C5D-8BCA-1A4462233FFFQ38797791-66EE996E-AF17-40D3-92FD-194BD0606A43Q39098635-DC532411-2C77-4AF0-8CEB-047D21EF513AQ44668981-894F1989-1543-43DE-AD59-EEED791C92ABQ45713741-1955534C-AF26-4D2D-8CFE-5C4EEB505F7FQ45713744-3751E926-1059-40ED-B884-ACC9A390DFD6Q48174168-B39AB3E0-0B33-42B1-AA4A-13090D7493DE
P2860
Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oral versus combination mesala ...... randomized multicentre study.
@ast
Oral versus combination mesala ...... randomized multicentre study.
@en
type
label
Oral versus combination mesala ...... randomized multicentre study.
@ast
Oral versus combination mesala ...... randomized multicentre study.
@en
prefLabel
Oral versus combination mesala ...... randomized multicentre study.
@ast
Oral versus combination mesala ...... randomized multicentre study.
@en
P2093
P2860
P1476
Oral versus combination mesala ...... randomized multicentre study.
@en
P2093
Beltrami M
Campieri M
Di Maurizio P
Fornaciari G
Gionchetti P
P2860
P304
P356
10.1046/J.1365-2036.2001.00913.X
P407
P577
2001-02-01T00:00:00Z